Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 279.40
-0.40 (-0.14%)
Apr 17, 2025, 12:59 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 8.80 billion as of April 21, 2025. Its market cap has increased by 5.63% in one year.
Market Cap
8.80B
Enterprise Value
8.42B
Revenue
822.42M
Ranking
n/a
PE Ratio
51.36
Stock Price
279.40
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 8.80B, an increase of 2,267.80%. That is a compound annual growth rate of 28.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 90.33B |
| Sectra AB | 52.95B |
| Getinge AB | 52.88B |
| Camurus AB | 33.19B |
| Medicover AB | 32.28B |
| Vitrolife AB | 20.94B |
| Bonesupport Holding AB | 20.38B |
| Vimian Group AB | 19.66B |